Auto makers were off, with Peugeot SA declining 3.2% and Renault SA down 2.3 %.
Heavyweight insulin maker Novo Nordisk AS slid 2.6% as the U.S. Food and Drug Administration delayed the approval of two new insulin drugs by three months.